NDC 17033-451 - Clavacillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17033-451
- Package NDCs from labels
- 17033-451-15
- Manufacturer
- Dechra Veterinary Products, LLC
- Effective date
- 2026-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clavacillin - Dechra Veterinary Products, LLC | Dechra Veterinary Products, LLC | 2026-04-03 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17033-451-15 | Clavacillin | 15 mL in 1 VIAL, GLASS | POWDER, FOR SUSPENSION | 15 | 5 | |
| 17033-451-15 | Clavacillin | 1 in 1 CARTON | POWDER, FOR SUSPENSION | 1 | 5 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | 6a078e7d-f942-4185-a131-50215d8e0a1e | 2026-02-25 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | AMOXICILLIN AND CLAVULANATE POTASSIUM | Sportpharm LLC | 3f9beabd-b579-460a-8ceb-789389b109f8 | 2026-02-20 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 77126eee-9534-4e80-9d11-ec78ec66c826 | 2026-02-19 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | bcd19a89-e9dc-b85f-e053-2a95a90a6f3e | 2026-02-19 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | NuCare Pharmaceuticals,Inc. | bd46de4c-4571-ba9a-e053-2a95a90a792d | 2026-02-19 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | NuCare Pharmaceuticals,Inc. | f1eee459-9021-b26e-e053-2995a90a7291 | 2026-02-18 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | PD-Rx Pharmaceuticals, Inc. | f229e8b4-7045-4c0d-9214-890c0bda3c2a | 2026-02-16 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | a3d1c0bb-94f3-4cfb-a4c6-233cf7e519a4 | 2026-02-13 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 483f6fca-e04e-4086-aa44-a361322b811d | 2026-02-13 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | A-S Medication Solutions | 8bce45db-dea7-4090-9d64-8b11b08d963e | 2026-02-12 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | NuCare Pharmaceuticals,Inc. | 800f5fac-f2af-358f-e053-2a91aa0ad6a6 | 2026-02-10 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 2a376d67-0bf2-43a1-8ca3-73f90689c339 | 2026-02-06 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Sportpharm LLC | 94b7c1bb-c024-4dc6-86d4-18a17a3eafcb | 2026-02-04 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | Sportpharm LLC | d55dd9d9-e901-47b6-b496-5f2749726a2e | 2026-02-03 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | REMEDYREPACK INC. | bb95fd06-f200-4de3-bfae-84d642d8e0f3 | 2026-02-02 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | NuCare Pharmaceuticals,Inc. | 776da91b-0626-1090-e053-2a91aa0a40f0 | 2026-01-28 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | 6a3f7e6c-fec2-41da-a070-00a02e64c920 | 2026-01-28 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals, Inc. | 88e76bdd-39f2-48c4-91ca-609511afd382 | 2026-01-26 | Warnings, Adverse reactions | 804826J2HU |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Preferred Pharmaceuticals Inc. | 16915fe9-1ac9-4ebb-afc8-eeb89144f30c | 2026-01-20 | Warnings, Adverse reactions | Q42OMW3AT8 804826J2HU |
| Amoxicillin | AMOXICILLIN | Preferred Pharmaceuticals Inc. | 0ce05282-995c-461e-b807-facb1fcbb405 | 2026-01-19 | Warnings, Adverse reactions | 804826J2HU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.